| Dr Sarah Elizabeth Vose, PT, DPT, MS, CIDN | |
|
25 Indian Rock Rd Ste 3, Windham, NH 03087-1691 | |
| (603) 458-7988 | |
| (603) 513-2833 |
| Full Name | Dr Sarah Elizabeth Vose |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 25 Indian Rock Rd Ste 3, Windham, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144271156 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Elizabeth Vose, PT, DPT, MS, CIDN 127 Rockingham Rd Ste 204, Windham, NH 03087-1360 Ph: (603) 458-7988 | Dr Sarah Elizabeth Vose, PT, DPT, MS, CIDN 25 Indian Rock Rd Ste 3, Windham, NH 03087-1691 Ph: (603) 458-7988 |
News Archive
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced today that it will a host an educational symposium featuring leading cardiovascular surgeons who will discuss the critical issues in caring for today's cardiovascular surgery patients.
Speaking this week at "the 99th Indian Science Congress, the country's largest annual gathering of scientists," Prime Minister Manmohan Singh "said the occasion demanded looking anew at the role of science in a country 'grappling with the challenges of poverty and development'" and "emphasized that 'the overriding objective of a comprehensive and well-considered policy for science, technology and innovation should be to support the national objective of faster, sustainable and inclusive development,'" SciDev.Net reports.
Over 90 per cent of physicians treating actinic keratosis (AK) prefer short duration treatment options with fast resolving local skin responses (LSRs), is the finding of a global study (‘Physician Perceptions and Experience of Current Treatment in Actinic Keratosis') that is being presented today at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV).
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
A study of nearly 4000 pairs of mothers and their children in the Children of the 90s study at the University of Bristol has shown that maternal vitamin D levels during pregnancy are not associated with the child's bone health in later life. The research, published Online First in The Lancet, is the largest ever observational study of the effects of mothers' vitamin D levels in pregnancy on their children's bone health, and suggests that UK health guidelines may be overstating the importance of vitamin D supplementation in pregnancy.
› Verified 8 days ago